Herbas VPB

Print
EN | LT
LT - Tulžies rūgšties dariniai, kaip FXR/TGR5 agonistai
EN - BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07J 41/00 (2006.01)
C07J 43/00 (2006.01)
A61K 31/56 (2006.01)
A61P 1/16 (2006.01)
A61P 3/10 (2006.01)
A61P 3/06 (2006.01)
A61P 3/04 (2006.01)
C07J 9/00 (2006.01)
C07J 51/00 (2006.01)
European patent
(11) Number of the document 3223822
(13) Kind of document T
(96) European patent application number 15864209.0
Date of filing the European patent application 2015-11-27
(97) Date of publication of the European application 2017-10-04
(45) Date of publication and mention of the grant of the patent 2020-07-01
(46) Date of publication of the claims translation 2020-10-12
PCT application
(86) Number PCT/US2015/062826
Date 2015-11-27
PCT application publication
(87) Number WO 2016/086218
Date 2016-06-02
Priority applications
(30) Number Date Country code
201462084769 P 2014-11-26 US
201562103374 P 2015-01-14 US
201514951989 2015-11-25 US
Inventors
(72)
WANG, Guoqiang, US
OR, Yat Sun, US
SHEN, Ruichao, US
LONG, Jiang, US
DAI, Peng, US
XING, Xuechao, US
HE, Jing, US
Grantee
(73) Enanta Pharmaceuticals, Inc., 500 Arsenal Street, Watertown, MA 02472, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Tulžies rūgšties dariniai, kaip FXR/TGR5 agonistai
  BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS
Last renewal fee
Payment date Validity (years) Amount
2022-11-23 8 185.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2023-11-27